GLYAT and cancer: We have previously reported that the penetrating peptide RT53, based on the fusion of the heptad leucine repeat region of the survival protein AAC-11 (residues 363–399) and the penetratin sequence, induces cancer cell death in vitro and inhibits melanoma tumor growth in a xenograft mouse model [22].